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Breast cancer aﬀects 1 in 8 women today.
1 The
treatment of breast diseases comprises 14–25% of
general surgeons practice volume.
2,3 Yet, approxi-
mately half of all general surgeons perform only two
or fewer breast cases per month. Unquestionably,
long-term survival after surgery for breast cancer
depends upon stage.
4 More recently, survival has
been linked to performance measures. For instance,
survival is greater at hospitals performing greater
than 125–150 breast cancer surgeries per year.
5–8
Additionally, survival is greater if surgeons perform
greater than 15 breast cancer operations per year.
8
Finally, completion of a surgical oncology fellowship
resulted in a 36% reduction in the risk of death at 5
years when controlled for hospital volume, surgeon
volume, age, stage, and race.
8–10 Can one infer from
these studies that ‘‘breast-focused’’ surgeons are more
competent? The criticisms of these studies have been
that they often emanate from authors who may be
prejudiced toward the results. In fact, there is an
observation that, if a surgeon works in a hospital
with a cancer center designation, the results from the
treatment of breast cancer are not based on any
speciﬁc surgical or breast disease training other than
the general surgical residence.
8 The implication
would be that the multimodality approach to the
treatment of the disease is the reason for any in-
creased survival rather than the judgmental or tech-
nical expertise of the surgeon.
Data compiled in 2006 by the American Board of
Surgery for surgeons recertifying at the 10-year, 20-
year, and 30-year levels is now available. To recertify,
a list of cases done in the year previous to application
for recertiﬁcation must be provided by the candidate.
Such data provides a snapshot of what is actually
being done by practicing general surgeons in this
country over a 30-year period. Fifty percent of gen-
eral surgeons do a maximum of 18 breast biopsies;
10% do between 18 and 65; and 1% do between 65
and 182. Corresponding numbers for modiﬁed radi-
cal mastectomies are that 50% of surgeons do 2; 25%
do 6; 10% do 11; and 1% do 34. The numbers for
lumpectomy and axillary dissection are that 50% of
surgeons do 2; 25% do 8; 10% do 17; and 1% do 81.
These numbers are remarkably similar for the sur-
geons at 10-, 20-, and 30-year recertiﬁcation time
points; likewise, for those surgeons in the upper 25%
category, the numbers are remarkably similar to the
numbers of these procedures done during a general
surgery residency prior to the advent of sentinel
lymph node biopsy.
11 Currently, these surgeons do
ten or more sentinel lymph node biopsies annually.
Interpretation of this data is that 25% of the
practicing surgeons do almost 90% of the surgery for
breast cancer. Essentially, none of the certifying
surgeons had completed an accredited breast fellow-
ship since these fellowships had not yet been estab-
lished. Nevertheless, these surgeons should be
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953qualiﬁed whether or not they work in an accredited
breast center since case volume alone should dictate
familiarity with the multidisciplinary treatment of
breast cancer. Consequently, any attempt to accredit
breast centers must protect these 25% of surgeons
regardless of practice, locale, or fellowship status, as
long as certain, yet to be deﬁned ‘‘quality measures’’
are met.
It appears that breast-focused surgeons have
identiﬁed themselves by the demographics of their
practices over the last 30 years and, without doubt,
are more competent than the 50% of surgeons who
do the occasional case. The issue then becomes the
competency of the surgeons ﬁnishing general surgery
residencies today. Currently, the Surgical Residency
Review Committee (SRRC) requires a total of 25
procedures to be preformed in the soft-tissue, skin,
and breast category. Data available for the 2004–
2005 graduating surgical residents demonstrates that
the average number of mastectomies performed,
partial or simple, with axillary sampling during
training was 21, but 17 of these were performed at the
junior resident level. Moreover, sentinel node biopsy
rates were a mean of seven per resident with a mode
of five, again primarily performed at the junior resi-
dency level. The obvious concern is that this experi-
ence may not be sufficient to guarantee competency.
In univariate and multivariate analyses, the experi-
ence of the surgeon (volume and specialization)
affected the rate of breast-conserving surgery.
12
Moreover, numerous studies have concluded that
performance of 20–30 sentinel lymph node biopsies
with completion axillary lymph node dissections or
mentoring by an experienced colleague is optimal to
minimize false-negative results.
13–16 As a result of the
advent of sentinel lymph node biopsy, the volume of
axillary dissections has diminished. In the presidential
address before the Society of Surgical Oncology
(SSO) in 1998,
11 the prediction was made that routine
use of sentinel lymph node biopsy would halve the
number of axillary dissections over the next 10 years.
In fact, in 1997 a resident at the University of Florida
performed an average of ten axillary dissections,
while the corresponding number for 2006 was six.
Nationally, residents completing general surgery
training in the United States performed 11 axillary
dissections in 2000, compared with 4.5 in 2006. Over
the same period, the number of sentinel lymph node
biopsies increased from 0 to 8.3. If most of the cases
are, in fact, done in the junior years and the cases are
fewer in comparison to the past, then one wonders
whether we are graduating ‘‘competent’’ breast sur-
geons. Because surgical residency experience varies
widely, perhaps those graduates who wish to treat
patients with breast cancer need to enter a practice
with one of the 25% who are competent, or they need
to complete a surgical oncology or breast fellowship
if they feel that their exposure was limited.
Currently,thenumberofavailablebreastfellowships
almostequalsthatforsurgicaloncology.Atthetimeof
the 2006 qualifying examination of the American
Board of Surgery, candidates were queried about
postgraduate fellowship enrollment. No documenta-
tion was required. Fellowships listed by the candidates
included breast (31), surgical oncology (43), pediatric
surgery (40), minimally invasive surgery (107), and
cardiothoracic surgery (111). The recent acceptance
ratewas77%forsurgicaloncologyand79%forbreast
fellowships. Clearly, it seems that the current genera-
tion of general surgery residents is choosing to enter a
narrower specialty than general surgery and many are
willing to give up the treatment of breast diseases.
Those who pursue breast fellowship training are
interested in advanced training in breast ultrasound,
image-guided biopsy (either ultrasound or stereotactic
guided), and specialized surgical techniques.
The issues of ultrasound and stereotactic biopsy are
rather more complicated. The American College of
Surgeons (ACS), the American Society of Breast
Surgeons (ASBrS), and most recently the SSO have
provided courses on ultrasound, to include the breast.
The courses are often oversubscribed. More recently
courses in stereotactic biopsy have been provided by
the ACS and the ASBrS. The recertiﬁcation numbers
for stereotactic breast biopsy reveal that 75% of the
surgeons do none. At 10-year recertiﬁcation, 10% do
13 and 1% do 70; at 20 year recertiﬁcation, 10% do 18
and 1% do 127; and at 30 year recertiﬁcation, 10% do
3 and 1% do 72. These data demonstrate that 10% of
surgeons do almost 100% of the stereotactic breast
biopsies. Possibly individuals who elect to perform
image-guided breast biopsies should be certiﬁed, since
these techniques are not routinely taught during a
general surgery residency. Both the ACS and the
ASBrS oﬀer stereotactic and breast ultrasound certi-
ﬁcation. Certiﬁcation demonstrates a dedication to
quality patient care and public safety through adher-
ence to established standards for performance and
training.
There is additional data to suggest that ‘‘breast-
focused’’ surgeons have better outcomes. For exam-
ple, surgical oncologists are 26% more likely to do
breast-conservation surgery than are general sur-
geons.
1 The authors postulate that surgical oncologist
have fewer positive margins resulting in fewer
re-excisions and, therefore, fewer mastectomies. As
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surgeons have been shown to have better satisfaction
with their care regardless of the gender of their sur-
geon, length of time in practice, or association with a
cancer center.
17 A recent study, somewhat damning
to our general surgery British colleagues, found that
survival from breast cancer was 20% worse when the
patients were not treated by a breast ‘‘specialist’’. The
authors concluded that this result was at least in part
due to inadequate local treatment, resulting in a
higher rate of local recurrence in the breast and
axilla.
18 Like most professions, the more concen-
trated the effort, the better the outcomes.
It can be argued that specialization improves out-
comes due to greater patient volume, enhanced tech-
nical ability, more integrated multimodality
treatment, use of advanced techniques, and enhanced
patient satisfaction. If this argument is accepted then
program directors need to incorporate breast specialty
training more into the traditional surgical residencies
of the present, especially at the more senior resident
levels to ensure adequately trained breast surgeons.
The current data from the SRRC supports specialty
fellowships to ensure an adequate number of surgeons
who are ‘‘breast focused’’. The optimal surgical resi-
dency program will evolve as new specialty pathways
modify the present postgraduate training programs. If
so, there may be less need for post residency specialty
fellowships or less need to spend the time in the cur-
rent traditional residency programs.
But what about the 25% of the surgeons who do
almost 90% of the surgery for breast cancer as de-
tailed above? These individuals should have improved
outcomes because of their case volume. Nevertheless,
it will be important for them to be continuously
aware of the advances in breast care, and implement
new evidence-based ﬁndings into their practice. These
actions will demonstrate their commitment to
improved outcomes and facilitate documentation of
the quality measures which ultimately will be
demanded by both patients and payers.
Our conclusion is that ‘‘breast-focused’’ surgeons
are more competent.
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